Tradewinds Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Tradewinds Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$509	Hold	15	–	–	﹤0.01%	647
2026 Q1	$452	Sell	15 -70	-82%	-$2.25K	﹤0.01%	651
2025 Q4	$2.65K	Buy	85 +70	+467%	+$1.72K	﹤0.01%	507
2025 Q3	$303	Hold	15	–	–	﹤0.01%	627
2025 Q2	$252	Hold	15	–	–	﹤0.01%	589
2025 Q1	$231	Hold	15	–	–	﹤0.01%	620
2024 Q4	$331	Hold	15	–	–	﹤0.01%	620
2024 Q3	$271	Hold	15	–	–	﹤0.01%	583
2024 Q2	$244	Hold	15	–	–	﹤0.01%	558
2024 Q1	$212	Hold	15	–	–	﹤0.01%	522
2023 Q4	$157	Hold	15	–	–	﹤0.01%	447
2023 Q3	$153	Hold	15	–	–	﹤0.01%	475
2023 Q2	$113	Buy	+15	New	+$122	﹤0.01%	455
2020 Q2	–	Sell	-465	Closed	-$4K	–	715
2020 Q1	$4K	Hold	465	–	–	﹤0.01%	488
2019 Q4	$5K	Hold	465	–	–	﹤0.01%	506
2019 Q3	$3K	Hold	465	–	–	﹤0.01%	502
2019 Q2	$4K	Hold	465	–	–	﹤0.01%	477
2019 Q1	$7K	Hold	465	–	–	﹤0.01%	434
2018 Q4	$7K	Hold	465	–	–	﹤0.01%	432
2018 Q3	$10K	Hold	465	–	–	﹤0.01%	418
2018 Q2	$11K	Buy	465 +265	+133%	+$5.4K	﹤0.01%	408
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	537
2017 Q4	$4K	Hold	200	–	–	﹤0.01%	535
2017 Q3	$4K	Hold	200	–	–	﹤0.01%	514
2017 Q2	$7K	Buy	+200	New	+$6.19K	﹤0.01%	447
2015 Q4	–	Sell	-28	Closed	-$2K	–	681
2015 Q3	$2K	Sell	28 -104	-79%	-$6.74K	﹤0.01%	553
2015 Q2	$8K	Buy	+132	New	+$8.14K	0.01%	445
2014 Q1	–	Sell	-200	Closed	-$8K	–	647
2013 Q4	$8K	Buy	+200	New	+$7.88K	0.01%	401

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Tradewinds Capital Management's TEVA Position: Q2 2026 in Review

Tradewinds Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 15 shares worth $509. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Tradewinds Capital Management first reported a position in TEVA in Q4 2013 and has held it in 28 quarters since. The position peaked at $11K in Q2 2018. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Tradewinds Capital Management held 15 shares of Teva Pharmaceuticals worth $509 as of Q2 2026.
Tradewinds Capital Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #647 holding.
Tradewinds Capital Management first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 28 quarters since.
Tradewinds Capital Management's Teva Pharmaceuticals position peaked at $11K in Q2 2018.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.